Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer, J. Clin. Oncol, vol.11, pp.1873-1878, 1993. ,
Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck, Cancer, vol.78, pp.1284-1292, 1996. ,
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival, J. Natl. Cancer Inst, vol.90, pp.824-832, 1998. ,
Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas, Head Neck, vol.13, pp.132-139, 1991. ,
Molecularly targeted therapy for the treatment of head and neck cancer: A review of the ErbB family inhibitors, OncoTargets Ther, vol.9, pp.1927-1943, 2016. ,
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck, N. Engl. J. Med, vol.354, pp.567-578, 2006. ,
New strategies in head and neck cancer: Understanding resistance to epidermal growth factor receptor inhibitors, Clin. Cancer Res, vol.16, pp.2489-2495, 2010. ,
Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance, Oncologist, vol.18, pp.850-864, 2013. ,
Blood Flow and Oxygenation Status of Head and Neck Carcinomas, Adv. Exp. Med. Biol, vol.428, pp.89-95, 1997. ,
Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer, Cancer Res, vol.61, pp.2911-2916, 2001. ,
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: Relationship to tumor biology and treatment outcome in surgically resected patients, Cancer Res, vol.62, pp.2493-2497, 2002. ,
Stabilisation and Knockdown of HIF-Two Distinct Ways Comparably Important in Radiotherapy, Cell. Physiol. Biochem, vol.28, pp.805-812, 2011. ,
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha, J. Biol. Chem, vol.280, pp.22473-22481, 2005. ,
The hypoxia-associated factor switches cells from HIF-1alpha-to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion, Cancer Res, vol.71, pp.4015-4027, 2011. ,
Generating specificity and diversity in the transcriptional response to hypoxia, Nat. Rev. Genet, vol.10, pp.821-832, 2009. ,
The impact of O2 availability on human cancer, Nat. Rev. Cancer, vol.8, pp.967-975, 2008. ,
Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome, Int. J. Mol. Sci, vol.18, p.1854, 2017. ,
Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance, PLoS ONE, vol.10, 2015. ,
Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions, Oncologist, vol.12, pp.690-712, 2007. ,
Differential pattern of HIF-1alpha expression in HNSCC cancer stem cells after carbon ion or photon irradiation: One molecular explanation of the oxygen effect, Br. J. Cancer, vol.116, pp.1340-1349, 2017. ,
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma, Oncotarget, vol.7, pp.74362-74379, 2016. ,
Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1alpha, Tumour Biol, vol.35, pp.10443-10448, 2014. ,
Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma, Mol. Cancer Ther, vol.8, pp.2255-2265, 2009. ,
Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models, Neoplasia, vol.14, pp.1005-1014, 2012. ,
mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations, J. Natl. Cancer Inst, vol.106, 2014. ,
Carbon ion radiotherapy of human lung cancer attenuates HIF-1 signaling and acts with considerably enhanced therapeutic efficiency, FASEB J, vol.28, pp.1412-1421, 2014. ,
The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1alpha, Cancer Lett, vol.322, pp.78-85, 2012. ,
Passing the baton: The HIF switch, Trends Biochem. Sci, vol.37, pp.364-372, 2012. ,
The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer, Cancer, vol.107, pp.757-766, 2006. ,
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer, Int. J. Radiat. Oncol, vol.53, pp.1192-1202, 2002. ,
Endothelial PAS domain-containing protein 1 confers TKI-resistance by mediating EGFR and MET pathways in non-small cell lung cancer cells, Cancer Boil. Ther, vol.16, pp.549-557, 2015. ,
Sorafenib resistance in hepatocarcinoma: Role of hypoxia-inducible factors, Exp. Mol. Med, vol.50, 2018. ,
Upregulation of HIF-2alpha induced by sorafenib contributes to the resistance by activating the TGF-alpha/EGFR pathway in hepatocellular carcinoma cells, Cell Signal, vol.26, pp.1030-1039, 2014. ,
Drug Resistance Driven by Cancer Stem Cells and Their Niche, Int. J. Mol. Sci, vol.18, 2017. ,
Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction, Stem Cells, vol.26, pp.1818-1830, 2008. ,
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217-and ALKBH5-mediated modulation of RNA methylation in breast cancer cells, Oncotarget, vol.7, pp.64527-64542, 2016. ,
HIF-2alpha regulates NANOG expression in human embryonic stem cells following hypoxia and reoxygenation through the interaction with an Oct-Sox cis regulatory element, PLoS ONE, vol.9, 2014. ,
HIF-2alpha promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways, J. Exp. Clin. Cancer Res, vol.37, 2018. ,
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head-and neck-cancer patients, Proc. Natl. Acad. Sci, vol.83, pp.2684-2688, 1986. ,
Characterization of a new surface epitope specific for human epithelial cells defined by a monoclonal antibody and application to tumor diagnosis, Cancer Res, vol.47, pp.4417-4424, 1987. ,
Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model, Anticancer Res, vol.19, pp.3827-3836, 1999. ,
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer, Naunyn-Schmiedebergs Arch. Pharmacol, vol.387, pp.505-521, 2014. ,
Effects of Smoking on the Pharmacokinetics of Erlotinib, Clin. Cancer Res, vol.12, pp.2166-2171, 2006. ,
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction, Cancers, vol.11, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02363219
Preclinical modeling of EGFR inhibitor resistance in head and neck cancer, Cancer Boil. Ther, vol.13, pp.935-945, 2012. ,
A simple practice guide for dose conversion between animals and human, J. Basic Clin. Pharm, vol.7, pp.27-31, 2016. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI